Overview
Amelia Lawrence is an Otolaryngologist in Seattle, Washington. Dr. Lawrence is rated as an Experienced provider by MediFind in the treatment of Periorbital Cellulitis. Her top areas of expertise are Periorbital Cellulitis, Anosmia, Obstructive Sleep Apnea, and Head and Neck Squamous Cell Carcinoma (HNSCC).
Her clinical research consists of co-authoring 17 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Periorbital Cellulitis.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Bryan Liming is a Pediatric Otolaryngologist and an Otolaryngologist in Tacoma, Washington. Dr. Liming is rated as an Advanced provider by MediFind in the treatment of Periorbital Cellulitis. His top areas of expertise are Laryngomalacia, Stridor, Laryngeal Cleft, Adenoidectomy, and Endoscopy. Dr. Liming is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AnosmiaDr. Lawrence isExperienced. Learn about Anosmia.
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Obstructive Sleep ApneaDr. Lawrence isExperienced. Learn about Obstructive Sleep Apnea.
- Periorbital CellulitisDr. Lawrence isExperienced. Learn about Periorbital Cellulitis.
- Sinus CancerDr. Lawrence isExperienced. Learn about Sinus Cancer.